E7766

STING agonist · Eisai Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for E7766, covering 2024-03-07 to 2024-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 [Phase 1]

See pricing